SCHEMBL514247

SCHEMBL514247

O=S(=O)(O)Oc1ccccc1OS(=O)(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.53
FABP1 P07148 1/20 0.49
CA5A P35218 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ELANE P08246 1/20 0.41
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
ALDH1A1 P00352 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
HSD11B1 P28845 1/20 0.35
HSD17B3 P37058 1/20 0.35
MAPT P10636 1/20 0.35
CHEK1 O14757 1/20 0.35
CA12 O43570 1/20 0.35
CA4 P22748 1/20 0.35
CA7 P43166 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28288293 0.97 SLC22A6 (0.52) SLC22A6FABP1CA5ATSHRSMN1; SMN2
Ammonia Solution, Strong SCHEMBL1278643 0.97 SLC22A6 (0.52) SLC22A6FABP1CA5ATSHRSMN1; SMN2
SCHEMBL1882763 0.97 SLC22A6 (0.52) SLC22A6FABP1CA5ATSHRSMN1; SMN2
SCHEMBL560230 0.89 CA1 (0.56) SLC22A6FABP1CA5ATSHRSMN1; SMN2
Potassium SCHEMBL4629084 0.87 CA1 (0.54) SLC22A6FABP1CA5ATSHRSMN1; SMN2
SCHEMBL235067 0.85 HSD11B1 (0.50) SLC22A6FABP1CA5ATSHRSMN1; SMN2
SCHEMBL29382842 0.85 HSD11B1 (0.50) SLC22A6FABP1CA5ATSHRSMN1; SMN2
SCHEMBL3827901 0.85 SLC22A6 (0.47) SLC22A6FABP1CA5ATSHRSMN1; SMN2
SCHEMBL3828196 0.85 SLC22A6 (0.43) SLC22A6FABP1CA5ATSHRSMN1; SMN2
SCHEMBL7526678 0.85 FABP1 (0.44) SLC22A6FABP1CA5ATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 297 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102046693-B Process for producing aliphatic polyester resin and aliphatic polyester resin composition TORAY FIBER RES INST CN CO LTD 2013-08-21 CN claimed
CN-102046693-A Process for producing aliphatic polyester resin and aliphatic polyester resin composition TORAY FIBER RES INST CN CO LTD 2011-05-04 CN claimed
EP-0873106-B1 USE OF METALLOFLUOROCOMPLEXES FOR DENTAL COMPOSITIONS MINNESOTA MINING & MFG (US) 2003-05-02 EP claimed
US-6391286-B1 CURABLE DENTAL COMPOSITION COMPRISING PREFORMED METAL COMPLEX AS FLUORIDE RELEASING MATERIAL 3M INNOVATIVE PROPERTIES COMPANY 2002-05-21 US claimed
EP-0873106-A1 USE OF METALLOFLUOROCOMPLEXES FOR DENTAL COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-10-28 EP claimed
WO-1997018791-A1 USE OF METALLOFLUOROCOMPLEXES FOR DENTAL COMPOSITIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-05-29 WO claimed
JP-57129900-A None JP disclosed
WO-2025080785-A1 METHODS AND MOLECULAR CONSTRUCTS FOR INCORPORATING MOLECULES INTO ELECTRICAL CIRCUITS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2025-04-17 WO disclosed
US-20250041213-A1 STABLE SOLID FINGOLIMOD DOSAGE FORM HANDA NEUROSCIENCE, LLC (US) 2025-02-06 US disclosed
US-12198868-B2 Solid electrolytic capacitor element and solid electrolytic capacitor PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2025-01-14 US disclosed
US-12191091-B2 Solid electrolytic capacitor element and solid electrolytic capacitor PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2025-01-07 US disclosed
US-20240050365-A1 STABLE SOLID FINGOLIMOD DOSAGE FORMS HANDA NEUROSCIENCE, LLC (US) 2024-02-15 US disclosed
US-20230282425-A1 SOLID ELECTROLYTIC CAPACITOR ELEMENT AND SOLID ELECTROLYTIC CAPACITOR PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2023-09-07 US disclosed
US-4804783-A Process for producing diphenylamines or N,N'-diphenyl-phenylenediamines MITSUI TOATSU CHEMICALS, INC. (JP) 1989-02-14 US disclosed
US-4758415-A Process for removing soluble metal cations in iron oxide pigments BASF CORPORATION (US) 1988-07-19 US disclosed
US-4374120-A Fluorescence spectroscopy assay means with fluorescent chelate of a lanthanide WALLAC OY (FI) 1983-02-15 US disclosed
JP-S57129900-A CHEMICAL ETCHING METHOD MITSUBISHI ELECTRIC CORP 1982-08-12 JP disclosed
US-4248676-A CHROMATING NIPPON STEEL CORPORATION (JP) 1981-02-03 US disclosed
US-4143075-A RHODIUM-CARBON MONOXIDE-TRIARYLPHOSPHINE CATALYST, SEQUESTERING IRON SALT CONTAMINANTS UNION CARBIDE CORPORATION (US) 1979-03-06 US disclosed
US-4035436-A METALS, HEAT RESISTANCE TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JA) 1977-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250041213-A1 STABLE SOLID FINGOLIMOD DOSAGE FORM S1PR4, S1PR2, S1PR5 SLC22A6 318/4885FABP1 1201/4885CA5A 4110/4885
US-20240050365-A1 STABLE SOLID FINGOLIMOD DOSAGE FORMS S1PR4, S1PR2, S1PR5 SLC22A6 888/4885FABP1 2334/4885CA5A 4006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.